Madrid, Spain
10 – 11 Feb 2026
Operationalizing AI: Turning proven AI use cases into everyday practice across life sciences.
SVP, Head of Regulatory Affairs and PV Operations
Astellas
SVP, Worldwide Patient Safety Officer
Bristol Myers Squibb
The latest release brings AI-powered Narrative Generation, enhanced Business Intelligence, and seamless data integrations, empowering life sciences companies to enhance patient safety, quality, and compliance.
The latest release brings AI-powered Narrative Generation, enhanced Business Intelligence, and seamless data integrations, empowering life sciences companies to enhance patient safety, quality, and compliance.
The multinational biopharma company, which previously used a series of on-premise point solutions, will implement LifeSphere Safety due to the platform’s AI-based innovation and modern multi-tenant cloud delivery.
By moving from legacy systems to LifeSphere® MultiVigilance, the organization anticipates significant efficiency gains.
By moving from legacy systems to LifeSphere® MultiVigilance, the organization anticipates significant efficiency gains.
With the cloud-based solution, Boehringer Ingelheim creates a global single source of truth for case management, leveraging automation and reducing infrastructure costs.
With the cloud-based solution, Boehringer Ingelheim creates a global single source of truth for case management, leveraging automation and reducing infrastructure costs.
Strategic collaboration strengthens end-to-end connectivity & data flow across the drug development platform, ensuring seamless interoperability across Clinical, Safety, Regulatory, Medical Affairs, and Quality platforms.
Eight net new LifeSphere customers, 300% YoY increase in customer go-lives, and delivering innovation via LifeSphere NavaX
ArisGlobal places all customers at the core of its operations.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved
